Bovine Mastitis Market Size & Growth Forecast 2027–2036, By Segments (Product, Type, Therapy, Route of Administration, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Bovine Mastitis Market size stood at USD 1.9 billion in 2026 and is predicted to grow at a 7.89% CAGR from 2027 to 2036, attaining USD 4.06 billion by 2036. The industry revenue for 2027 is assessed at USD 2.03 billion.
Get more details on this report
Request Free Sample ReportBovine Mastitis Market Intelligence Snapshot
Regional Market Dynamics
- North America holds 40.00% share, supported by large commercial dairy herds, established veterinary networks, and routine on-farm diagnostics and treatment practices.
- Asia Pacific grows at 9.38% CAGR due to dairy modernization, rising productivity focus, and expanding adoption of structured herd health and mastitis control systems.
Segment Momentum
- Pharmaceuticals held a 61.95% share in 2026 because they remain the primary treatment for active mastitis infections, with antibiotics and supportive therapies routinely used in veterinary practice and farm treatment protocols.
- Vaccines are growing fastest as dairy producers increasingly adopt preventive herd health strategies to reduce recurring infections, strengthen udder health management, and lessen reliance on repeated pharmaceutical treatments.
Market Expansion Drivers
- Rising global dairy consumption increasing demand for effective udder infection management solutions.
- Advancements in molecular diagnostics improving early detection and treatment accuracy for mastitis.
- Growing awareness of subclinical mastitis driving preventive veterinary healthcare adoption.
Leading Market Participants
- Major players in the bovine mastitis market include Zoetis Inc. (United States), Boehringer Ingelheim International GmbH (Germany), Elanco Animal Health Incorporated (United States), Merck & Co., Inc. (United States), Ceva Santé Animale S.A. (France), HIPRA, S.A. (Spain), Virbac S.A. (France), ImmuCell Corporation (United States), Forte Healthcare Limited (New Zealand), Dechra Pharmaceuticals PLC (United Kingdom).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.9 billion
- 2027 Estimated Market Size: USD 2.03 billion.
- Projected Market Size: USD 4.06 billion by 2036
- Growth Forecast: 7.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Pharmaceuticals (Product) | Clinical Mastitis (Type) | Dry Period (Therapy) | Intra-Mammary (Route of Administration) | Veterinary Hospitals/Clinics (End-use)
- Emerging Opportunity Segment: Vaccines (Product) | Sub-Clinical Mastitis (Type) | Lactating Period (Therapy) | Intra-Mammary (Route of Administration) | Veterinary Hospitals/Clinics (End-use)
Market Growth Drivers and Industry Trends
Rising global dairy consumption increasing demand for effective udder infection management solutions
Rising dairy consumption is supporting the bovine mastitis market by increasing the importance of maintaining healthy and productive dairy herds to meet milk production requirements. Mastitis can impair udder health and affect milk quality, creating economic and operational challenges for dairy producers when infections are not identified and managed effectively. As dairy farming systems focus on maintaining herd productivity and meeting quality expectations, producers require reliable approaches for prevention, diagnosis, treatment, and monitoring of udder infections. Veterinary medicines, diagnostic tools, herd management practices, and hygiene protocols therefore play an important role in maintaining animal health across expanding dairy production activities.
Advancements in molecular diagnostics improving early detection and treatment accuracy for mastitis
Advances in molecular diagnostic technologies are strengthening the bovine mastitis market by enabling more precise identification of pathogens and infection-related characteristics at an earlier stage. Molecular methods can provide detailed information about the microorganisms associated with mastitis, supporting veterinarians in distinguishing between different infectious causes and selecting more appropriate treatment strategies. Earlier and more accurate detection can also reduce delays in intervention and help producers monitor herd health before infections develop into more severe clinical conditions. Improvements in diagnostic sensitivity, pathogen identification, and laboratory workflows are expanding the role of advanced testing alongside conventional approaches to mastitis management.
Growing awareness of subclinical mastitis driving preventive veterinary healthcare adoption
Greater recognition of subclinical mastitis is encouraging a more preventive approach to dairy herd health, supporting demand across the bovine mastitis market as producers seek to identify infections that may not show obvious clinical symptoms. Subclinical cases can remain difficult to detect through visual observation while still affecting milk quality, udder health, and herd productivity, making routine monitoring increasingly important. Veterinary healthcare programs that incorporate regular screening, somatic cell monitoring, hygiene management, nutritional support, and targeted intervention can help producers identify potential problems before they become more difficult to manage. Increased awareness among dairy producers and veterinary professionals is consequently strengthening the emphasis on continuous udder-health surveillance and preventive herd management practices.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global dairy consumption increasing demand for effective udder infection management solutions | 1.90% | Moderate | Asia Pacific, North America | High | Near Term |
| Advancements in molecular diagnostics improving early detection and treatment accuracy for mastitis | 1.70% | High | North America, Europe | Medium | Mid Term |
| Growing awareness of subclinical mastitis driving preventive veterinary healthcare adoption | 1.40% | Moderate | Asia Pacific, Latin America | Emerging | Mid Term |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
North America dominated the bovine mastitis market with a 40.00% share in 2026, supported by advanced dairy farming practices, strong veterinary healthcare infrastructure, and high awareness of herd health management. Dairy producers in the region increasingly emphasize early detection, prevention, and treatment of mastitis to protect animal welfare and maintain milk quality and farm productivity. The adoption of diagnostic technologies, improved milking hygiene, veterinary services, and preventive herd-management protocols is strengthening demand for effective mastitis management solutions. Regulatory attention to milk quality and food safety further encourages producers to implement structured disease-control practices, while the commercial scale and professionalization of dairy operations create favorable conditions for continued investment in animal health and disease prevention.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is experiencing the fastest market development, driven by expanding dairy production, rising demand for milk and dairy products, and gradual modernization of livestock farming practices. Growing awareness of the economic and productivity consequences of mastitis is encouraging farmers to place greater emphasis on animal health, hygiene, and disease monitoring. Improvements in veterinary service availability and increasing adoption of organized dairy management practices are creating opportunities for diagnostic, therapeutic, and preventive solutions. At the same time, the transition from small-scale traditional farming toward more commercialized dairy operations is supporting greater adoption of systematic herd-health programs. Rising attention to food safety and milk quality is further encouraging producers to strengthen mastitis prevention and management, supporting the region's rapid market expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Preventive Dairy ManagementGermany emphasizes preventive mastitis control through veterinary oversight, herd monitoring, and responsible therapeutic practices. Dairy operations in Germany continue strengthening disease surveillance to maintain animal health and support consistent milk production standards.
France 🇫🇷
Herd Monitoring StrategiesFrance focuses on comprehensive udder health management through routine screening, veterinary guidance, and preventive farm practices. Dairy producers in France are integrating monitoring technologies with herd management programs to improve treatment planning and milk quality outcomes.
Italy 🇮🇹
Veterinary Treatment OptimizationItaly strengthens bovine mastitis management through improved diagnostics, targeted treatment protocols, and preventive herd care. Dairy producers in Italy continue refining veterinary decision-making to support healthier livestock and more efficient dairy operations.
Japan 🇯🇵
Dairy Quality AssuranceJapan prioritizes early mastitis detection and consistent herd health management to support high-quality dairy production. Producers in Japan increasingly adopt diagnostic technologies that enable timely intervention while reducing production losses associated with udder infections.
South Korea 🇰🇷
Modern Livestock CareSouth Korea is expanding veterinary management practices supported by improved dairy health monitoring and disease detection tools. Dairy farms in South Korea continue investing in practical mastitis management solutions that enhance animal welfare and operational consistency.
United States 🇺🇸
Precision Herd HealthThe U.S. bovine mastitis market centers on preventive herd health management supported by advanced diagnostics and data-driven dairy monitoring. Dairy producers in the U.S. increasingly adopt integrated disease management strategies that improve milk quality and treatment efficiency.
Segment Leadership and Growth Trends
Bovine Mastitis Market Share (%), by Product, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportProduct Segment Analysis: Pharmaceuticals (Largest Segment) vs Vaccines (Fastest-Growing Segment)
The pharmaceuticals segment dominated the bovine mastitis market with a 61.95% share in 2026, supported by its established role in treating and managing bacterial infections and inflammation affecting dairy cattle. Pharmaceutical therapies remain widely used for addressing active mastitis cases, helping producers protect animal health and minimize disruptions to milk production. The broad availability of therapeutic options and established veterinary treatment practices continue to reinforce the segment's position. In addition, greater emphasis on herd health management and timely intervention is encouraging the continued use of pharmaceutical treatments as part of mastitis control programs.
Vaccines are expected to be the fastest-growing product segment as the focus of bovine mastitis management increasingly shifts toward prevention rather than relying solely on treatment after infection occurs. Preventive immunization can support herd health by strengthening disease resistance and reducing the burden associated with recurring mastitis cases. Growing awareness of preventive veterinary care, combined with the need to improve livestock productivity and reduce treatment-related challenges, is creating greater interest in vaccination strategies. The expanding emphasis on comprehensive herd health programs is therefore supporting the adoption of vaccines as an important tool for mastitis prevention.
Type Segment Analysis: Clinical Mastitis (Largest Segment) vs Sub-Clinical Mastitis (Fastest-Growing Segment)
Clinical mastitis represented the largest segment of the bovine mastitis market in 2026, reflecting the immediate and visible impact of clinically apparent infections on animal health and dairy operations. Cases characterized by noticeable changes in the udder, milk, or overall animal condition typically require prompt veterinary attention and treatment, generating sustained demand for diagnostic and therapeutic interventions. The direct effect of clinical disease on animal welfare and milk quality also encourages producers to prioritize rapid identification and management, supporting the segment's leading position.
The sub-clinical mastitis segment is anticipated to be the fastest-growing segment as dairy producers increasingly recognize the economic and herd-health implications of infections that may not produce obvious clinical symptoms. Greater adoption of herd monitoring, milk-quality assessment, and preventive health management is improving the ability to identify these less visible cases. Early detection allows producers to address infection before it develops into more severe disease and helps protect overall herd productivity. Increasing awareness of hidden production losses and the importance of proactive mastitis management is consequently strengthening demand within the sub-clinical mastitis segment.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Product | Pharmaceuticals, Antibiotics, Vaccines, Diagnostics, Others | Pharmaceuticals | Vaccines |
| Type | Clinical Mastitis, Sub-Clinical Mastitis | Clinical Mastitis | Sub-Clinical Mastitis |
| Therapy | Dry Period, Lactating Period | Dry Period | Lactating Period |
| Route of Administration | Intra-Mammary, Systemic | Intra-Mammary | Intra-Mammary |
| End-use | Veterinary Hospitals/Clinics, Others | Veterinary Hospitals/Clinics | Veterinary Hospitals/Clinics |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Prominent players in the bovine mastitis market:
1. Zoetis Inc. (United States)
2. Boehringer Ingelheim International GmbH (Germany)
3. Elanco Animal Health Incorporated (United States)
4. Merck & Co. Inc. (United States)
5. Ceva Santé Animale S.A. (France)
6. HIPRA S.A. (Spain)
7. Virbac S.A. (France)
8. ImmuCell Corporation (United States)
9. Forte Healthcare Limited (New Zealand)
10. Dechra Pharmaceuticals PLC (United Kingdom)
The bovine mastitis market is experiencing growing innovation as dairy producers seek effective disease prevention and herd health management solutions. Manufacturers are developing advanced therapeutic formulations, diagnostic technologies, and preventive treatment strategies aimed at reducing infection rates and improving milk quality. Rising awareness regarding livestock productivity and animal health standards is further supporting expansion within the bovine mastitis market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. (United States) | |||||||
| Boehringer Ingelheim International GmbH (Germany) | |||||||
| Elanco Animal Health Incorporated (United States) | |||||||
| Merck & Co. Inc. (United States) | |||||||
| Ceva Santé Animale S.A. (France) | |||||||
| HIPRA S.A. (Spain) | |||||||
| Virbac S.A. (France) | |||||||
| ImmuCell Corporation (United States) | |||||||
| Forte Healthcare Limited (New Zealand) | |||||||
| Dechra Pharmaceuticals PLC (United Kingdom). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boehringer Ingelheim | Apr-26 | Boehringer Ingelheim expanded its livestock health portfolio with the EU-wide launch of LENZELTA®, a mastitis vaccine for dairy cattle. This commercialization effort focuses on preventive immunization to mitigate the incidence and severity of clinical mastitis, providing dairy producers with a strategic tool to enhance herd management and operational health outcomes. |
| AHV USA | Apr-25 | AHV USA established a strategic distribution partnership with Milk Barn to integrate molecular diagnostic technology with real-time dairy monitoring systems. This collaboration seeks to improve the speed and accuracy of early mastitis detection, demonstrating a shift toward technology-enabled management solutions aimed at optimizing herd health and reducing productivity losses in dairy operations. |
| Biotangents | Nov-24 | Biotangents secured £2.3 million in funding led by Eos Advisory, with participation from British Business Investments, Kelvin Capital, and Scottish Enterprise. This capital infusion is earmarked to accelerate the development and commercialization of advanced diagnostic technologies, aiming to improve the detection and clinical management of bovine mastitis within livestock health operations. |
| Zoetis | Aug-23 | Zoetis commercialized the Vetscan Mastigram, an on-farm diagnostic test capable of identifying Gram-positive mastitis within eight hours. By enabling rapid testing prior to the subsequent milking cycle in European markets, this product provides a functional innovation that allows for more timely therapeutic interventions and improved decision-making in bovine mastitis management. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Bovine Mastitis Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Pathogen Type | Gram-Positive Bacteria, Gram-Negative Bacteria, Mycoplasma, Fungal/Other Pathogens |
| Farm Size | Small Farms, Medium Farms, Large Farms, Industrial/Dairy Operations |
| Cattle Production Type | Dairy Cattle, Beef Cattle, Dual-Purpose Cattle |
Bovine Mastitis Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Dairy Farm Disease Prevention Economics |
|
| Milk Quality and Compliance Impact Assessment |
|
| Antibiotic Stewardship and Alternative Therapies Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current revenue of the bovine mastitis market?
How much is the bovine mastitis industry expected to grow by 2036?
How are dairy productivity priorities influencing adoption of mastitis management solutions?
How are advanced diagnostics changing treatment strategies in the bovine mastitis market?
Why do pharmaceuticals lead the bovine mastitis market?
Why are vaccines the fastest-growing product segment in the bovine mastitis market?
Why does North America lead the bovine mastitis market?
What is driving Asia Pacific’s growth in bovine mastitis market?
Which companies are driving growth in the bovine mastitis landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization